Compare FMS & GRAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FMS | GRAB |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | Germany | Singapore |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 12.3B |
| IPO Year | 2005 | 2021 |
| Metric | FMS | GRAB |
|---|---|---|
| Price | $22.29 | $2.88 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $30.00 | $6.53 |
| AVG Volume (30 Days) | 591.6K | ★ 46.4M |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.57% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $24.04 |
| Revenue Next Year | $3.83 | $20.98 |
| P/E Ratio | ★ $15.62 | $74.17 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.02 | $2.74 |
| 52 Week High | $27.64 | $6.62 |
| Indicator | FMS | GRAB |
|---|---|---|
| Relative Strength Index (RSI) | 38.80 | 32.02 |
| Support Level | $21.95 | N/A |
| Resistance Level | $22.59 | $3.98 |
| Average True Range (ATR) | 0.30 | 0.13 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 27.48 | 15.91 |
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore, Indonesia, and Malaysia contributed more than 70% of revenue in 2024. Grab's main competitors in Southeast Asia are Line Man and Goto. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.